Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v52,p1877)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferguson, S. C.
Right arrow Articles by Frier, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferguson, S. C.
Right arrow Articles by Frier, B. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:145-148, 2003
© 2003 by the American Diabetes Association, Inc.

Apolipoprotein-E Influences Aspects of Intellectual Ability in Type 1 Diabetes

Stewart C. Ferguson1, Ian J. Deary2, Julie C. Evans3, Sian Ellard3, Andrew T. Hattersley3, and Brian M. Frier1

1 Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh, Scotland, U.K.
2 Department of Psychology, University of Edinburgh, Edinburgh, Scotland, U.K.
3 Centre for Molecular Genetics, Exeter University, Exeter, England, U.K.

The {epsilon}4 allele of the apolipoprotein-E (APOE) gene is associated with poor outcome following various cerebral insults. The relationship between APOE genotype and cognitive function in patients with type 1 diabetes is unknown. In a cross-sectional study of 96 people with type 1 diabetes, subjects were APOE genotyped, previous exposure to severe hypoglycemia was estimated by questionnaire, and cognition was assessed by neuropsychological testing. Cognitive abilities were compared using multivariate general linear modeling (multiple analysis of covariance, MANCOVA) in those with (n = 21) and without (n = 75) the APOE {epsilon}4 allele. APOE {epsilon}4 selectively influenced cognitive ability in a sex-specific manner (F = 2.3, P = 0.044, Eta2 = 0.15); women with APOE {epsilon}4 performed less well on tests of current, nonverbal intellectual ability (Wechsler Adult Intelligence Scale-Revised performance test score, P = 0.001, Eta2 0.26) and frontal lobe and executive function (Borkowski verbal fluency, P = 0.016, Eta2 = 0.15). Previous exposure to severe hypoglycemia did not interact with APOE {epsilon}4 to produce cognitive disadvantage. The APOE {epsilon}4 genotype is associated with specific cognitive disadvantage in young women with type 1 diabetes. APOE {epsilon}4 is unlikely to mediate susceptibility to hypoglycemia-induced cognitive disadvantage.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
K. E. Burdick, T. Lencz, B. Funke, C. T. Finn, P. R. Szeszko, J. M. Kane, R. Kucherlapati, and A. K. Malhotra
Genetic variation in DTNBP1 influences general cognitive ability
Hum. Mol. Genet., May 15, 2006; 15(10): 1563 - 1568.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
N Scarmeas, C G Habeck, J Hilton, K E Anderson, J Flynn, A Park, and Y Stern
APOE related alterations in cerebral activation even at college age
J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1440 - 1444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.